Biomarin Pharmaceutical Inc (BMRN)

Days of sales outstanding (DSO)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Receivables turnover		3.75	4.48	4.91	4.07	4.45
DSO	days	97.42	81.40	74.36	89.76	81.98

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.75
= 97.42

To analyze Biomarin Pharmaceutical Inc's days of sales outstanding (DSO) over the past five years, we can observe the trend in the DSO ratio. DSO represents the average number of days it takes for a company to collect payments after making a sale.

- In 2023, the DSO increased to 97.42 days compared to the previous year, indicating that Biomarin took longer to collect payments from customers in 2023.
- The DSO in 2022 was 81.40 days, showing a decrease from 2021. This suggests that the company improved its collections process and reduced the average number of days to collect payments.
- In 2021, the DSO was 74.36 days, reflecting a further reduction from 2020. This signifies an even more efficient collection of receivables compared to the previous year.
- The DSO in 2020 increased to 89.76 days from 2019, indicating a longer collection period that year.
- In 2019, the DSO was 81.98 days, showing a slightly lower number of days required to collect payments compared to 2020.

Overall, Biomarin Pharmaceutical Inc's DSO has fluctuated in the past five years, with improvements in collection efficiency in some years and increases in others. Analyzing DSO trends can provide insights into the company's accounts receivable management and cash flow performance.